C-Peptide Market Trends: Global Brand Comparison, Product Efficacy, and Industry Insights
Abstract: The global C-peptide market is driven by its critical role in diabetes management and emerging therapeutic applications. Brand comparison reveals significant efficacy variations, with synthetic analogs offering higher purity but higher costs versus recombinant options. Key parameters include molecular weight ( 3.6 kDa) and stability. Industry insights highlight a shift toward GMP-certified facilities and cold-chain logistics compliance. Leading brands prioritize ISO 13485 and FDA approvals, while product composition (e.g., zinc content) directly impacts bioactivity. Market trends project 6.8% CAGR through 2030, fueled by expanded use in neuropathy treatment and insulin secretion assessment.